3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Thyroid Neoplasms
2
Myelodysplastic Syndromes
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tobacco Use Disorder
1
Thyroid Nodule
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Monoclonal Gammopathy of Undetermined Significance
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Anemia
1
Interventions
Colposcopy
13
Imiquimod
12
Conization
11
Papillomavirus Vaccines
8
Cryotherapy
6
Vaccines
5
Papanicolaou Test
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Acetic Acid
4
Watchful Waiting
3
Vaginal Smears
3
Surveys and Questionnaires
3
Biopsy
3
human papillomavirus vaccine, L1 type 16, 18
2
Spectrometry, Fluorescence
2
Proflavine
2
Mass Screening
2
Immunohistochemistry
2
Human Papillomavirus DNA Tests
2
High-Throughput Screening Assays
2
Flow Cytometry
2
Curcumin
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
efineptakin alfa
1
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Dysplasia
×
Molecular Diagnostic Techniques
×
Clear all
NCT02328872
2026-04-17
Compass
VCS Foundation
Phase NA
Active not recruiting
76,181 enrolled